BRPI0406746A - Preparado de combinação contra tontura - Google Patents

Preparado de combinação contra tontura

Info

Publication number
BRPI0406746A
BRPI0406746A BR0406746-0A BRPI0406746A BRPI0406746A BR PI0406746 A BRPI0406746 A BR PI0406746A BR PI0406746 A BRPI0406746 A BR PI0406746A BR PI0406746 A BRPI0406746 A BR PI0406746A
Authority
BR
Brazil
Prior art keywords
combination preparation
preparation against
dizziness
combination
against dizziness
Prior art date
Application number
BR0406746-0A
Other languages
English (en)
Inventor
Helga Schleenhain
Original Assignee
Hennig Arzneimittel Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hennig Arzneimittel Gmbh & Co filed Critical Hennig Arzneimittel Gmbh & Co
Publication of BRPI0406746A publication Critical patent/BRPI0406746A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"PREPARADO DE COMBINAçãO CONTRA TONTURA". A presente invenção refere-se à aplicação de cinarizina e dimenidrinato ou de seus sais fisiologicamente toleráveis em combinação para o tratamento de tontura de qualquer gênese.
BR0406746-0A 2003-01-15 2004-01-14 Preparado de combinação contra tontura BRPI0406746A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10301981A DE10301981A1 (de) 2003-01-15 2003-01-15 Kombinationspräparat gegen Schwindel
PCT/DE2004/000072 WO2004064843A2 (de) 2003-01-15 2004-01-14 Kombination zur behandlung von schwindel, welche cinnarizin und dimenhydrinat enthält

Publications (1)

Publication Number Publication Date
BRPI0406746A true BRPI0406746A (pt) 2005-12-20

Family

ID=32602769

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0406746-0A BRPI0406746A (pt) 2003-01-15 2004-01-14 Preparado de combinação contra tontura

Country Status (11)

Country Link
US (3) US20060135533A1 (pt)
EP (2) EP1622622A2 (pt)
JP (2) JP2006515610A (pt)
KR (1) KR20050092106A (pt)
CN (1) CN1738626A (pt)
BR (1) BRPI0406746A (pt)
CA (1) CA2511948A1 (pt)
DE (1) DE10301981A1 (pt)
PL (1) PL378180A1 (pt)
RU (1) RU2005125062A (pt)
WO (1) WO2004064843A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10301981A1 (de) * 2003-01-15 2004-07-29 Hennig Arzneimittel Gmbh & Co. Kg Kombinationspräparat gegen Schwindel
DE102005014142B4 (de) * 2005-03-23 2006-11-09 Hennig Arzneimittel Gmbh & Co. Kg Pelletförmige Retardzubereitung gegen Schwindel
DE102005014141B4 (de) * 2005-03-23 2006-12-21 Hennig Arzneimittel Gmbh & Co. Kg Tablettenförmige Retardzubereitung gegen Schwindel
WO2011024029A1 (en) * 2009-08-24 2011-03-03 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Fast disintegrating dosage forms of cinnarizine and dimenhydrinate combination
CN109170773A (zh) * 2018-10-09 2019-01-11 河南科技大学 一种宇航员用防眩晕功能食品的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2499058A (en) 1950-02-28 B-haloxantfflne salts of diarylalkyl
US2882271A (en) 1959-04-14 Xcixcxh
US2534813A (en) 1950-01-21 1950-12-19 Searle & Co 8-haloxanthine salts of cyclic-aminoalkyl benzohydryl ethers and the production thereof
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
DE10301981A1 (de) * 2003-01-15 2004-07-29 Hennig Arzneimittel Gmbh & Co. Kg Kombinationspräparat gegen Schwindel
DE102005014142B4 (de) * 2005-03-23 2006-11-09 Hennig Arzneimittel Gmbh & Co. Kg Pelletförmige Retardzubereitung gegen Schwindel
DE102005014141B4 (de) * 2005-03-23 2006-12-21 Hennig Arzneimittel Gmbh & Co. Kg Tablettenförmige Retardzubereitung gegen Schwindel

Also Published As

Publication number Publication date
US20090137602A1 (en) 2009-05-28
US20120157475A1 (en) 2012-06-21
EP1622622A2 (de) 2006-02-08
RU2005125062A (ru) 2006-01-27
EP2174690A1 (de) 2010-04-14
PL378180A1 (pl) 2006-03-06
CA2511948A1 (en) 2004-08-05
WO2004064843A2 (de) 2004-08-05
WO2004064843A3 (de) 2004-12-23
JP2011140502A (ja) 2011-07-21
JP2006515610A (ja) 2006-06-01
KR20050092106A (ko) 2005-09-20
CN1738626A (zh) 2006-02-22
US20060135533A1 (en) 2006-06-22
DE10301981A1 (de) 2004-07-29

Similar Documents

Publication Publication Date Title
BR0312165A (pt) Utilização da taurina para o tratamento da alopecia
UY26269A1 (es) Formulación de sal común y moxifloxacina
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
DK2842569T3 (da) Vaccination i en dosis med Mycoplasma hyopneumoniae
BRPI0510808A (pt) derivados de benzonitrila para tratar fragilidade musculoesquelética
BRPI0416796A (pt) compostos orgánicos
BRPI0519195A2 (pt) composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal
BRPI0517971A (pt) composições dentifrìcias contendo zinco e tendo um gosto aprimorado
BR0012590A (pt) Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de dor ou desconforto, e para tratamento ou profilaxia de dor neuropática ou central
CY1107615T1 (el) Θεραπευτικοι συνδυασμοι αντιυπερτασικων και αντιαγγειογενετικων παραγοντων
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
BRPI0615157A2 (pt) composto, composição farmacêutica, métodos para inibir a replicação viral em um paciente humano, e para tratar uma infecção viral em um paciente humano, e, uso de um composto
BRPI0407897A (pt) derivados de cianopiridina úteis no tratamento de cáncer e outros distúrbios
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
CY1110162T1 (el) Φαρμακοτεχνικη μορφη και μεθοδοι για την αγωγη της θρομβοκυτταραιμιας
BRPI0508596A (pt) combinação compreendendo ligante alfa-2-delta
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
BR0307410A (pt) Uso de inibidores de pde5 no tratamento da cicatrização e fibrose
NO20024646L (no) Kombinasjonsterapier med vaskul¶r-skadende aktivitet
BRPI0606528A8 (pt) composição para uso no fabrico de medicamentos de tratamento da infertilidade masculina e uso da mesma
DE502004011851D1 (de) Caspase 3, 8, 9 oder 10 Inhibitoren in Kombination mit MEK Inhibitoren zur Behandlung von Influenza
DE50101034D1 (de) Medizinischer oder dentalmedizinischer behandlungsstuhl
BRPI0415781A (pt) método para o tratamento de diabetes em um paciente e kit farmacêutico

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 31/522 , A61P 1/08

Ipc: A61K 31/496 (2006.01), A61K 31/522 (2006.01), A61P

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 10, 11 E 13 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.